Table 2 Descriptive analysis of corporate governance statements for 2014–2018 period
Analyzed company | Fully/Partially/Non-Implemented Requirements | Calculated conformity rate (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Implemented | Partially | Non- | N/A | ||||||
Nr. | (%) | Nr. | (%) | Nr. | (%) | Nr. | (%) | ||
A | 41 | 100,00 | 0 | 0,00 | 0 | 0,00 | 0 | 0,00 | 100 |
B | 23 | 56,10 | 5 | 12,20 | 13 | 31,71 | 0 | 0,00 | 47,5 |
C | 40 | 97,56 | 1 | 2,44 | 0 | 0,00 | 0 | 0,00 | 95 |
D | 39 | 95,12 | 0 | 0,00 | 1 | 2,44 | 1 | 2,44 | 100 |
E | 38 | 92,68 | 0 | 0,00 | 2 | 4,88 | 1 | 2,44 | 99 |
F | 25 | 60,98 | 7 | 17,07 | 8 | 19,51 | 1 | 2,44 | 66,8 |
TOTAL | 209 | – | 13 | – | 24 | – | 3 | – | – |
Pharmaceutical industry means | 33,60 | 80,49 | 2,60 | 6,34 | 4,80 | 11,71 | 0,60 | 1,46 | 84,72 |